Calcium-channel blockers: Pharmacologic considerations
- 30 September 1982
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 104 (3), 665-671
- https://doi.org/10.1016/0002-8703(82)90254-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Beneficial enhancement of coronary blood flow by nifedipineAmerican Journal Of Medicine, 1981
- Verapamil in the Treatment of HypertensionJournal of Cardiovascular Pharmacology, 1981
- Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic EffectsAnnals of Internal Medicine, 1980
- Hemodynamic effects of nifedipine in congestive heart failureThe American Journal of Cardiology, 1980
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980
- Nifedipine: A myocardial protective agentThe American Journal of Cardiology, 1979
- Role of calcium and cyclic adenosine 3′:5′ monophosphate in regulating smooth muscle contraction: Mechanisms of excitation-contraction coupling in smooth muscleThe American Journal of Cardiology, 1979
- Calcium and cardiac excitation-contraction coupling.Annual Review of Physiology, 1979
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977
- The effect of the internal sodium concentration on calcium fluxes in isolated guinea‐pig auriclesThe Journal of Physiology, 1970